Publications by Year: 2015

2015
Sadeghpour, A. ; Rappolt, M. ; Ntountaniotis, D. ; Chatzigeorgiou, P. ; Viras, K. ; Megariotis, G. ; Papadopoulos, M. G. ; Siapi, E. ; Mali, G. ; Mavromoustakos, T. Comparative Study Of Interactions Of Aliskiren And At<inf>1</inf> Receptor Antagonists With Lipid Bilayers. Biochimica et Biophysica Acta - Biomembranes 2015, 1848, 984 - 994. Website
Kellici, T. ; Ntountaniotis, D. ; Vrontaki, E. ; Liapakis, G. ; Moutevelis-Minakakis, P. ; Kokotos, G. ; Hadjikakou, S. ; Tzakos, A. G. ; Afantitis, A. ; Melagraki, G. ; et al. Rational Drug Design Paradigms: The Odyssey For Designing Better Drugs. Combinatorial Chemistry and High Throughput Screening 2015, 18, 238 - 256. Website
Vrontaki, E. ; Leonis, G. ; Avramopoulos, A. ; Papadopoulos, M. G. ; Simčič, M. ; Grdadolnik, S. G. ; Afantitis, A. ; Melagraki, G. ; Hadjikakou, S. K. ; Mavromoustakos, T. Stability And Binding Effects Of Silver(I) Complexes At Lipoxygenase-1. Journal of Enzyme Inhibition and Medicinal Chemistry 2015, 30, 539 - 549. Website
Kollatos, N. ; Manta, S. ; Dimopoulou, A. ; Parmenopoulou, V. ; Triantakonstanti, V. V. ; Kellici, T. ; Mavromoustakos, T. ; Schols, D. ; Komiotis, D. Branched-Chain Sugar Nucleosides: Stereocontrolled Synthesis And Bioevaluation Of Novel 3′-C-Trifluoromethyl And 3′-C-Methyl Pyranonucleosides. Carbohydrate Research 2015, 407, 170 - 178. Website
Kellici, T. F. ; Ntountaniotis, D. ; Leonis, G. ; Chatziathanasiadou, M. ; Chatzikonstantinou, A. V. ; Becker-Baldus, J. ; Glaubitz, C. ; Tzakos, A. G. ; Viras, K. ; Chatzigeorgiou, P. ; et al. Investigation Of The Interactions Of Silibinin With 2-Hydroxypropyl-Β-Cyclodextrin Through Biophysical Techniques And Computational Methods. Molecular Pharmaceutics 2015, 12, 954 - 965. Website
Kellici, T. F. ; Tzakos, A. G. ; Mavromoustakos, T. Rational Drug Design And Synthesis Of Molecules Targeting The Angiotensin Ii Type 1 And Type 2 Receptors. Molecules 2015, 20, 3868 - 3897. Website
Vrontaki, E. ; Mavromoustakos, T. ; Melagraki, G. ; Afantitis, A. Quantitative Nanostructure-Activity Relationship Models For The Risk Assessment Of Nanomaterials. In Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment; 2015; pp. 535 - 559. Website
Vrontaki, E. ; Melagraki, G. ; Mavromoustakos, T. ; Afantitis, A. Exploiting Chembl Database To Identify Indole Analogs As Hcv Replication Inhibitors. Methods 2015, 71, 4 - 13. Website
Kordopati, G. G. ; Tselios, T. V. ; Kellici, T. ; Merzel, F. ; Mavromoustakos, T. ; Grdadolnik, S. G. ; Tsivgoulis, G. M. A Novel Synthetic Luteinizing Hormone-Releasing Hormone (Lhrh) Analogue Coupled With Modified Β-Cyclodextrin: Insight Into Its Intramolecular Interactions. Biochimica et Biophysica Acta - General Subjects 2015, 1850, 159 - 168. Website
Tzoupis, H. ; Leonis, G. ; Avramopoulos, A. ; Reis, H. ; Czyznikowska, Z. ; Zerva, S. ; Vergadou, N. ; Peristeras, L. D. ; Papavasileiou, K. D. ; Alexis, M. N. ; et al. Elucidation Of The Binding Mechanism Of Renin Using A Wide Array Of Computational Techniques And Biological Assays. Journal of Molecular Graphics and Modelling 2015, 62, 138 - 149. Website
Vrontaki, E. ; Melagraki, G. ; Afantitis, A. ; Tsantili-Kakoulidou, A. ; Mavromoustakos, T. 3D Quantitative Structure - Activity Relationships (3D - Qsar): A Short Overview. Pharmakeftiki 2015, 27, 126 - 137. Website
Kellici, T. F. ; Liapakis, G. ; Tzakos, A. G. ; Mavromoustakos, T. Pharmaceutical Compositions For Antihypertensive Treatments: A Patent Review. Expert Opinion on Therapeutic Patents 2015, 25, 1305 - 1317. Website